Ajanta Pharma Limited

NSE: AJANTPHARM

Compare with…

Employs 10,421 permanent employees and workers, 8.2% on the year before, as filed for the year to 31 Mar 2026 on a group basis. Revenue in the quarter to 31 Dec 2024 was ₹1,102 cr.

Headcount

Annual, from the BRSR filed with NSE (as of 31 March each year)

Permanent
Contract / other
As ofScopePermanentChange (%)Contract / otherChange (%)
31 Mar 2022Standalone7,234—2,348—
31 Mar 2023Standalone7,713479(6.6%)2,557209(8.9%)
31 Mar 2024Group⚠8,073360(4.7%)2,295−262(10.3%)
31 Mar 2025Group9,6281,555(19.3%)2,609314(13.7%)
31 Mar 2026Group10,421793(8.2%)2,785176(6.8%)
  • ⚠The reporting scope changed from the previous period, so the two are not comparable.

Permanent = permanent employees + permanent workers, as defined in SEBI's BRSR. "Standalone" figures cover the listed company alone and exclude its subsidiaries.

Financials (₹ cr)

Revenue (₹ cr)
Employee cost (₹ cr)
Net profit (₹ cr)
PeriodRevenue (₹ cr)Change (%)Employee cost (₹ cr)Change (%)Net profit (₹ cr)Change (%)Flags
Quarter ended 31 Dec 20241,102−27(2.4%)2464(1.7%)25217(7.2%)
Quarter ended 30 Sept 20241,12952(4.8%)242−24(9.0%)235−1(0.4%)
Quarter ended 30 Jun 20241,077151(16.3%)26650(23.2%)23673(44.8%)
Quarter ended 31 Mar 2024926−159(14.6%)2160(0.0%)163−57(25.9%)
Quarter ended 31 Dec 20231,085140(14.8%)21611(5.4%)2208(3.8%)
Quarter ended 30 Sept 2023945−70(6.9%)2059(4.6%)2120(0.0%)
Quarter ended 30 Jun 20231,015166(19.6%)196−11(5.3%)21295(81.2%)
Quarter ended 31 Mar 2023849−26(3.0%)20731(17.6%)117−7(5.7%)
Quarter ended 31 Dec 2022875109(14.2%)17630(20.5%)124−11(8.2%)⚠
Quarter ended 31 Mar 2022766−43(5.3%)146−2(1.4%)135−60(30.8%)⚠
Quarter ended 31 Dec 2021809−15(1.8%)1481(0.7%)195−2(1.0%)⚠
Quarter ended 30 Sept 202182481(10.9%)1472(1.4%)1974(2.1%)⚠
Quarter ended 30 Jun 2021743−5(0.7%)14512(9.0%)19338(24.5%)⚠
Quarter ended 31 Mar 202174815(2.1%)13310(8.1%)155−25(13.9%)⚠
Quarter ended 31 Dec 202073356(8.3%)1235(4.2%)180−45(20.0%)⚠
Quarter ended 30 Sept 2020677116(20.7%)118−6(4.8%)225109(94.0%)⚠
Quarter ended 30 Jun 20205610(0.0%)1247(6.0%)11627(30.3%)⚠
Quarter ended 31 Mar 202056130(5.7%)11710(9.3%)89−19(17.6%)⚠
Quarter ended 31 Dec 2019531−28(5.0%)1071(0.9%)108−13(10.7%)⚠
Quarter ended 30 Sept 201955913(2.4%)106−1(0.9%)121−3(2.4%)⚠
Quarter ended 30 Jun 2019546132(31.9%)10710(10.3%)12483(202.4%)⚠
Quarter ended 31 Mar 2019414−38(8.4%)97−3(3.0%)41−54(56.8%)⚠
Quarter ended 31 Dec 2018452−13(2.8%)1003(3.1%)95−9(8.6%)⚠
Quarter ended 30 Sept 20184652(0.4%)970(0.0%)10426(33.3%)⚠
Quarter ended 31 Mar 2018463—97—78—⚠